These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 8441024

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Stability of regional cerebral glucose metabolism in the normal brain measured by positron emission tomography.
    Tyler JL, Strother SC, Zatorre RJ, Alivisatos B, Worsley KJ, Diksic M, Yamamoto YL.
    J Nucl Med; 1988 May; 29(5):631-42. PubMed ID: 3259623
    [Abstract] [Full Text] [Related]

  • 23. Validation of postinjection transmission measurements for attenuation correction in neurological FDG-PET studies.
    Hooper PK, Meikle SR, Eberl S, Fulham MJ.
    J Nucl Med; 1996 Jan; 37(1):128-36. PubMed ID: 8543982
    [Abstract] [Full Text] [Related]

  • 24. Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: demonstration of principle.
    Martinez ZA, Colgan M, Baxter LR, Quintana J, Siegel S, Chatziioannou A, Cherry SR, Mazziotta JC, Phelps ME.
    Am J Primatol; 1997 Jan; 42(3):215-24. PubMed ID: 9209586
    [Abstract] [Full Text] [Related]

  • 25. Effect of cervical spinal cord stimulation (cSCS) on cerebral glucose metabolism and blood flow in a vegetative patient assessed by positron emission tomography (PET) and single photon emission computed tomography (SPECT).
    Momose T, Matsui T, Kosaka N, Ohtake T, Watanabe T, Nishikawa J, Abe K, Tanaka J, Takakura K, Iio M.
    Radiat Med; 1989 Jan; 7(5):243-6. PubMed ID: 2629037
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Regional cerebral metabolic rate for glucose in subacute sclerosing panencephalitis.
    Yanai K, Iinuma K, Tada K, Miyabayashi S, Fukuda H, Ito M, Matsuzawa T.
    Eur J Pediatr; 1987 May; 146(3):288-9. PubMed ID: 3496222
    [Abstract] [Full Text] [Related]

  • 28. Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects.
    Maquet P, Dive D, Salmon E, von Frenckel R, Franck G.
    Eur J Nucl Med; 1990 May; 16(4-6):267-73. PubMed ID: 2351175
    [Abstract] [Full Text] [Related]

  • 29. Regional cerebral glucose consumption measured by positron emission tomography in patients with Wilson's disease.
    Kuwert T, Hefter H, Scholz D, Milz M, Weiss P, Arendt G, Herzog H, Loken M, Hennerici M, Feinendegen LE.
    Eur J Nucl Med; 1992 May; 19(2):96-101. PubMed ID: 1563446
    [Abstract] [Full Text] [Related]

  • 30. The use of spectral analysis to determine regional cerebral glucose utilization with positron emission tomography and [18F]fluorodeoxyglucose: theory, implementation, and optimization procedures.
    Turkheimer F, Moresco RM, Lucignani G, Sokoloff L, Fazio F, Schmidt K.
    J Cereb Blood Flow Metab; 1994 May; 14(3):406-22. PubMed ID: 8163583
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Noninvasive measurement of blood flow, oxygen consumption, and glucose utilization in the same brain regions in man by positron emission tomography: concise communication.
    Baron JC, Lebrun-Grandie P, Collard P, Crouzel C, Mestelan G, Bousser MG.
    J Nucl Med; 1982 May; 23(5):391-9. PubMed ID: 6978932
    [Abstract] [Full Text] [Related]

  • 35. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
    Mishina M, Senda M, Ohyama M, Ishii K, Kitamura S, Terashi A.
    Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Hemocirculation and metabolism in intraventricular tumors: kinetic analysis of glucose metabolism].
    Shioya H, Mineura K, Kowada M, Iida H, Murakami M, Ogawa T, Hatazawa J, Uemura K.
    No Shinkei Geka; 1996 Mar; 24(3):211-9. PubMed ID: 8851949
    [Abstract] [Full Text] [Related]

  • 38. Effect of gender on glucose utilization rates in healthy humans: a positron emission tomography study.
    Miura SA, Schapiro MB, Grady CL, Kumar A, Salerno JA, Kozachuk WE, Wagner E, Rapoport SI, Horwitz B.
    J Neurosci Res; 1990 Dec; 27(4):500-4. PubMed ID: 2079712
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Clinical application of 18F-FDG-PET in patients with brain death].
    Momose T, Nishikawa J, Watanabe T, Ohtake T, Sasaki Y, Sasaki M, Mii K.
    Kaku Igaku; 1992 Sep; 29(9):1139-42. PubMed ID: 1453564
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.